Firm
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Laura Achával, founder of Achával IP in Argentina, shares how an evolving vision led her to launch her own practice
Sponsored
Sponsored
-
Sponsored by CASCAS explains how intellectual property intelligence enables biologics companies to reduce R&D risk, extend market exclusivity, and unlock commercial value in an increasingly competitive pharmaceutical landscape -
Sponsored by CASCAS examines how AI is changing prior art searches, reshaping intellectual property professional roles, and raising new challenges around data quality, governance, and legal accountability
-
Sponsored by Saint Island International Patent & Law OfficesAn Intellectual Property & Commercial Court ruling offers guidance on assessing trademark use for general merchandise retail services and specific goods retail services, explains Julia Y M Hung of Saint Island International Patent & Law Offices
-
Sponsored by CASAn effective intellectual property strategy helps green chemistry companies reduce R&D risk, secure competitive advantage, and translate scientific innovation into sustainable commercial success, as explained by CAS
-
Sponsored by CASCAS outlines how intellectual property practitioners can combine multi-source research, advanced techniques, and AI tools to uncover prior art and strengthen legal analysis
-
Sponsored by Becerril, Coca & BecerrilSoledad Betanzos-Lara of Becerril, Coca & Becerril explains how Mexico’s pharmaceutical and biotech patentability criteria are being reshaped by evolving examination practice
